UNSPSC 51332883: Triflupromazine maleate

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C18H19F3N2S.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17EKO3WVAY, chemically known as 10h-phenothiazine-10-propanamine, n,n-dimethyl-2-(trifluoromethyl)-, (2z)-2-butenedioate (1:1), but more generally known as triflupromazine maleate, which bears US NIH Compound Identifier 5568.

European Medicines Agency schedules triflupromazine maleate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11290MIG. Most nations, for tariff purposes, schedule triflupromazine maleate under HS 29343090. SMILES: CN(C)CCCN1C2CCCCC2SC3C1CC(CC3)C(F)(F)F.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51332883 Triflupromazine maleate is a Commodity code that, based on recent state and local activity, does not capture the pharmaceutical procurement actually occurring under this classification. The three recent opportunities tagged to this code involve naloxone procurement (emergency overdose reversal), generic multi-source pharmaceuticals and OTC products distributed through cooperative purchasing, and a request for information on direct-to-manufacturer prescription programs — none of which align with triflupromazine maleate, an antipsychotic medication. State and local governments are using this code to solicit broad pharmaceutical supply, formulary contracting, and pharmacy benefit program services rather than a specific chemical entity. The issuing bodies include county health departments (Seminole County, Florida), state health agencies and cooperative purchasing alliances (Texas Health and Human Services Commission, Minnesota Department of Administration through MMCAP), and participating jurisdictions across multiple states relying on multistate purchasing vehicles.

Recent activity spans Florida, Texas, and Minnesota. Seminole County issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, requiring electronic submission through the county's e-Procurement Portal and compliance with E-Verify and drug-free workplace certification. The Texas Health and Human Services Commission posted a Request for Information (RFI HHS0017013, April 3, 2026) exploring vendor capacity for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager and wholesaler channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic pharmaceuticals and OTC products to be supplied through three authorized wholesalers (Cencora, Cardinal Health, Morris & Dickson), with pricing weighted at 75 percent of evaluation and products required available by May 15, 2026 for a July 1, 2026 contract effective date. This code shows significant activity in cooperative and multistate procurement vehicles, with emphasis on cost management, formulary compliance, and supply chain efficiency across state and local health systems.